SAOL THERAPEUTICS
Saol Therapeutics is a biotech pharmaceutical company. At Saol Therapeutics, patients with diseases who are underserved for whatever reason are so much more than statistics. They are patients who deserve a chance at improved health. They are patients who need to be heard and who need to be helped. These patient populations with unmet needs are the reason they are passionately committed to bringing therapies for serious and often life-threatening diseases and conditions to healthcare providers.
SAOL THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care
Founded:
2015-01-01
Address:
Roswell, Georgia, United States
Country:
United States
Website Url:
http://www.saolrx.com
Total Employee:
11+
Status:
Active
Contact:
770-274-2470
Email Addresses:
[email protected]
Total Funding:
16.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Allero Therapeutics
Allero Therapeutics is a biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Cannpal Animal Therapeutics
Cannpal Animal Therapeutics is an Australia-based pet pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Quell Therapeutics
Quell Therapeutics is a cell therapy company
Samsung Bioepis
Samsung Bioepis is a biopharmaceutical company.
Zentera Therapeutics
Zentera Therapeutics is a biopharmaceutical company.
Current Employees Featured
Official Site Inspections
http://www.saolrx.com Semrush global rank: 3.4 M Semrush visits lastest month: 4.61 K
- Host name: 142.93.255.109
- IP address: 142.93.255.109
- Location: North Bergen United States
- Latitude: 40.793
- Longitude: -74.0247
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07047
More informations about "Saol Therapeutics"
Our Team – Saolrx
Martin Reynell joined Saol in 2016 and currently serves as the Sr. Director of Quality, where he has responsibilities for all quality management systems and product release for the …See details»
Saol Therapeutics - LinkedIn
Saol Therapeutics | 4,494 followers on LinkedIn. Saol Therapeutics (pronounced "Sail") is a privately held, clinical-stage, pharmaceutical company with operations in Roswell, GA, Dublin, …See details»
Saol Therapeutics - Crunchbase Company Profile & Funding
Saol Therapeutics is a biotech pharmaceutical company. At Saol Therapeutics, patients with diseases who are underserved for whatever reason are so much more than statistics.See details»
Saol Therapeutics - Overview, News & Similar companies - ZoomInfo
Oct 4, 2022 Saol Therapeutics contact info: Phone number: (770) 274-2476 Website: www.saolrx.com What does Saol Therapeutics do? Saol Therapeutics is committed to …See details»
Saol Therapeutics - LinkedIn
Saol Therapeutics | 4,425 followers on LinkedIn. Saol Therapeutics (pronounced "Sail") is a privately held, clinical-stage, pharmaceutical company with operations in …See details»
Saol Therapeutics CEO and Key Executive Team | Craft.co
Saol Therapeutics's Chief Executive Officer is David Penake. Other executives include Virinder Nohria, Chairman; Sharon Hamm, Senior Vice President of Development and 5 others. See …See details»
About Saol – Saolrx
In only five years, the company quickly grew to a robust commercial and clinical development organization, building to nearly 100 employees with operations located around the world. In …See details»
Working At Saol Therapeutics: Company Overview and Culture
Saolrx.com. Organization Type. Private. Social Media. Saol Therapeutics is a biotech pharmaceutical company. At Saol Therapeutics, patients with diseases who are underserved …See details»
Business Development – Saolrx
At Saol, our business development philosophy is to seek strategic partnerships in areas that could help serve patients and companies better. We invest early on in validating the needs and …See details»
Saol Therapeutics Announces Enrollment Achievement in Pivotal …
Oct 4, 2022 For more information, visit www.saolrx.com. About Medosome Biotec. Medosome Biotec, LLC is a privately held, preclinical and early-stage clinical pharmaceutical company …See details»
Amneal Acquires Saol Therapeutics’ Baclofen Franchise
Jan 5, 2022 - Expands Amneal’s Neurology Presence into Spasticity Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) and Saol Therapeutics, a private specialty pharmaceutical …See details»
Saol Therapeutics Announces FDA Approval of LYVISPAH™ …
Dec 7, 2021 David Penake, CEO of Saol Therapeutics stated, "We are tremendously excited by the approval of LYVISPAH ™.Spasticity is a challenging condition to treat, and we have …See details»
Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients …
ROSWELL, Ga., March 1, 2022 /PRNewswire/ -- Saol Therapeutics, a company researching new treatments for rare diseases, is pleased to announce a collaboration with GeneDx, Inc. a …See details»
Saol Therapeutics Receives Golden Helix Innovation Award from …
Feb 13, 2023 In 2022, Saol Therapeutics transformed from a global commercial organization to a late-stage development company. In the last 18 months, Saol divested all commercialized …See details»
Saol Therapeutics - Craft
Saol Therapeutics has 5 employees across 3 locations and $16.7 m in total funding,. See insights on Saol Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
Saol Therapeutics Announces First Patient Enrolled in Phase 2 …
May 3, 2022 The primary endpoint is the overall safety profile of a single treatment exposure of SL-1002 in comparison to placebo. Secondary endpoints include, but are not limited to, …See details»
Proposal Guidelines for Third-Party Funding Requests - Saolrx
For any questions, email [email protected]. for assistance. All Funding Requests . Timeline . Submission of any funding requests must be submitted at least 90 days in advance of the …See details»
Pipeline - Saolrx
You are now leaving saolrx.com and connecting to a site that is not under the control of Saol Therapeutics. Please be aware that Saol Therapeutics is not responsible for the contents of …See details»
Saol Therapeutics Announces FDA Approval of LYVISPAH™ …
Dec 7, 2021 ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, Dec. 7, 2021 /PRNewswire/ -- Saol Therapeutics today announced that the U.S. Food and Drug …See details»